Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Xi'an Jiaotong UniversityNo recent work listed

Pei Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6710-2816; OpenAlex author ID A5100738724. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper

Papers 2

  1. miR-221/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases. First author DOI 10.18632/oncotarget.3686↗
  2. Upregulated miR-106a plays an oncogenic role in pancreatic cancer. Co-author DOI 10.1016/j.febslet.2014.01.007↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jianjun Lei · 2 shared papers, 2014–2015 · strength 0.08
  2. Qingyong Ma · 2 shared papers, 2014–2015 · strength 0.08
  3. Zheng Wu · 2 shared papers, 2014–2015 · strength 0.08
  4. Wanxing Duan · 2 shared papers, 2014–2015 · strength 0.08
  5. Qinhong Xu · 2 shared papers, 2014–2015 · strength 0.08
  6. Xuqi Li · 2 shared papers, 2014–2015 · strength 0.08
  7. Liang Zong · 1 shared paper, 2015 · strength 0.04
  8. Ligang Nan · 1 shared paper, 2015 · strength 0.04
  9. Zheng Wang · 1 shared paper, 2015 · strength 0.04
  10. Zhengdong Jiang · 1 shared paper, 2015 · strength 0.04
  11. Liang Han · 1 shared paper, 2014 · strength 0.04
  12. Zheng Wang · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.